CBDNewsBreaks – LiveWire Ergogenics Inc. (LVVV)
Post# of 230
(Total Views: 590)
Posted On: 11/08/2019 5:02:56 PM
CBDNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Establishes Research Team to Study CBD-Based Treatments for High-Performance Horses
LiveWire Ergogenics (OTC: LVVV), a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry, has formed a dedicated research team to explore the efficacy of CBD for the treatment of specific ailments in high-performance horses. An article discussing the company reads, “The soon-to-commence research project will explore the potential application of CBD for high-performance horses in the hunter/jumper and dressage sectors. The research will target ‘the use, efficacy, safety and future of CBD’ for treating equine joint inflammation, anxiety, gastronomical disorders and pain as well as supporting general well-being (http://cnw.fm/4BOz3). Its motive is to ‘accelerate the advancement of the medical knowledge in the field, support the continuing effort for further legalization and eventually provide credible and high-quality applications that will benefit the entire equestrian field,’ the company’s news release states.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
LiveWire Ergogenics (OTC: LVVV), a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry, has formed a dedicated research team to explore the efficacy of CBD for the treatment of specific ailments in high-performance horses. An article discussing the company reads, “The soon-to-commence research project will explore the potential application of CBD for high-performance horses in the hunter/jumper and dressage sectors. The research will target ‘the use, efficacy, safety and future of CBD’ for treating equine joint inflammation, anxiety, gastronomical disorders and pain as well as supporting general well-being (http://cnw.fm/4BOz3). Its motive is to ‘accelerate the advancement of the medical knowledge in the field, support the continuing effort for further legalization and eventually provide credible and high-quality applications that will benefit the entire equestrian field,’ the company’s news release states.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)